Vik Bajaj

Director at Interline Therapeutics

Vik Bajaj is a managing director at Foresite Capital, evaluating and pursuing investments at the intersection of technology and life sciences. Prior to joining Foresite Capital and co-founding Foresite Labs, Vik was the chief scientific officer of GRAIL. He was also co-founder and former chief scientific officer of Verily and served as chair of its Scientific Advisory Board. Vik retains appointments as associate professor (consulting) at the Stanford School of Medicine, and as an affiliate scientist of the Lawrence Berkeley National Laboratory and the University of California, Berkeley, for which he serves on the advisory board of the College of Chemistry. He is an advisor to the Department of Defenses Science Board’s Task Force on Biology.

Vik’s research interests lie at the interface of the physical sciences, engineering, and the life sciences. He holds a Ph.D. in physical chemistry from the Massachusetts Institute of Technology. Vik’s scientific and engineering awards include the Anatole Abragam Prize (2012), the R&D 100 Award for the most promising commercialized technologies (2011 and 2013), and the Department of Energy’s LBL Innovation Grant (2013).

Timeline

  • Director

    Current role